Adiponectin receptor expression in gastric carcinoma: implications in tumor development and progression

  • Eun Shin
  • Do Joong Park
  • Hyung-Ho Kim
  • Nam Hee Won
  • Gheeyoung Choe
  • Hye Seung Lee
Original Paper



Adiponectin, an adipocyte-secreted endogenous insulin sensitizer, appears to play an important role in progression of several malignancies. Expression of adiponectin receptors—AdipoR1 and AdipoR2—has been documented in gastric cancer (GC) cell lines, but its role in GCs is still controversial. We investigated expression level of 2 adiponectin receptors and correlated their expression with prognosis in GC patients.


We immunohistochemically evaluated AdipoR1 and AdipoR2 expression in 59 non-neoplastic gastric mucosas, 48 gastric adenomas, 250 GCs, and 58 lymph nodes involved by metastatic GC and assessed its association with clinicopathologic characteristics.


Expression rates of both receptors increased stepwise in non-neoplastic gastric mucosa, gastric adenoma, intestinal-type GC, and metastatic GC (p < 0.001). AdipoR1 and AdipoR2 expression was observed in 85 (34.0 %) and 118 (47.2 %) GC cases, respectively. Expression rates were higher in intestinal-type GC than in diffuse-type GC (p < 0.001 and 0.016, respectively). AdipoR1 and AdipoR2 expression was more frequent in advanced GC than in early GC (p < 0.001, each) and was associated with lymphatic invasion (p = 0.046 and 0.001, respectively). AdipoR2 expression was associated with poor overall and disease-free survival (p = 0.001 and 0.007, respectively). AdipoR1 expression was associated with poor disease-free survival for intestinal-type GC patients (p = 0.046). In multivariate analysis, AdipoR2 was an independent prognostic factor for intestinal-type GC (p = 0.017).


Adiponectin receptor expression is related to GC development and progression, especially intestinal-type GC. Thus, adiponectin receptor expression can serve as a prognostic marker in GC patients.


Gastric carcinoma Adiponectin receptor Prognosis Immunohistochemistry 

Supplementary material

432_2013_1379_MOESM1_ESM.doc (86 kb)
Supplementary material 1 (DOC 86 kb)
432_2013_1379_MOESM2_ESM.doc (2.2 mb)
Supplementary material 2 (DOC 2208 kb)
432_2013_1379_MOESM3_ESM.doc (2.5 mb)
Supplementary material 3 (DOC 2599 kb)


  1. Arditi JD, Venihaki M, Karalis KP, Chrousos GP (2007) Antiproliferative effect of adiponectin on MCF7 breast cancer cells: a potential hormonal link between obesity and cancer. Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolism 39 (1):9–13. doi:10.1055/s-2007-956518
  2. Barresi V, Grosso M, Giuffre G, Tuccari G, Barresi G (2009) The expression of adiponectin receptors Adipo-R1 and Adipo-R2 is associated with an intestinal histotype and longer survival in gastric carcinoma. J Clin Pathol 62(8):705–709. doi:10.1136/jcp.2009.066175 PubMedCrossRefGoogle Scholar
  3. Byeon JS, Jeong JY, Kim MJ, Lee SM, Nam WH, Myung SJ, Kim JG, Yang SK, Kim JH, Suh DJ (2010) Adiponectin and adiponectin receptor in relation to colorectal cancer progression. Int J Cancer 127(12):2758–2767. doi:10.1002/ijc.25301 PubMedCrossRefGoogle Scholar
  4. Carneiro F, Sobrinho-Simoes M (1996) Metastatic pattern of gastric carcinoma. Hum Pathol 27(2):213–214PubMedCrossRefGoogle Scholar
  5. Chen DC, Chung YF, Yeh YT, Chaung HC, Kuo FC, Fu OY, Chen HY, Hou MF, Yuan SS (2006) Serum adiponectin and leptin levels in Taiwanese breast cancer patients. Cancer Lett 237(1):109–114. doi:10.1016/j.canlet.2005.05.047 PubMedCrossRefGoogle Scholar
  6. Chen MJ, Yeh YT, Lee KT, Tsai CJ, Lee HH, Wang SN (2012) The promoting effect of adiponectin in hepatocellular carcinoma. J Surg Oncol 106(2):181–187. doi:10.1002/jso.23059 PubMedCrossRefGoogle Scholar
  7. Chiu YC, Shieh DC, Tong KM, Chen CP, Huang KC, Chen PC, Fong YC, Hsu HC, Tang CH (2009) Involvement of AdipoR receptor in adiponectin-induced motility and alpha2beta1 integrin upregulation in human chondrosarcoma cells. Carcinogenesis 30(10):1651–1659. doi:10.1093/carcin/bgp156 PubMedCrossRefGoogle Scholar
  8. Chou SH, Tseleni-Balafouta S, Moon HS, Chamberland JP, Liu X, Kavantzas N, Mantzoros CS (2010) Adiponectin receptor expression in human malignant tissues. Horm Cancer 1(3):136–145. doi:10.1007/s12672-010-0017-7 PubMedCrossRefGoogle Scholar
  9. Dalamaga M, Migdalis I, Fargnoli JL, Papadavid E, Bloom E, Mitsiades N, Karmaniolas K, Pelecanos N, Tseleni-Balafouta S, Dionyssiou-Asteriou A, Mantzoros CS (2009) Pancreatic cancer expresses adiponectin receptors and is associated with hypoleptinemia and hyperadiponectinemia: a case-control study. CCC 20(5):625–633. doi:10.1007/s10552-008-9273-z PubMedGoogle Scholar
  10. Denzel MS, Hebbard LW, Shostak G, Shapiro L, Cardiff RD, Ranscht B (2009) Adiponectin deficiency limits tumor vascularization in the MMTV-PyV-mT mouse model of mammary cancer. Clin Cancer Res Off J Am Assoc Cancer Res 15(10):3256–3264. doi:10.1158/1078-0432.CCR-08-2661 CrossRefGoogle Scholar
  11. Dos Santos E, Benaitreau D, Dieudonne MN, Leneveu MC, Serazin V, Giudicelli Y, Pecquery R (2008) Adiponectin mediates an antiproliferative response in human MDA-MB 231 breast cancer cells. Oncol Rep 20(4):971–977PubMedGoogle Scholar
  12. Gialamas SP, Petridou ET, Tseleni-Balafouta S, Spyridopoulos TN, Matsoukis IL, Kondi-Pafiti A, Zografos G, Mantzoros CS (2011) Serum adiponectin levels and tissue expression of adiponectin receptors are associated with risk, stage, and grade of colorectal cancer. Metab, Clin Exp 60(11):1530–1538. doi:10.1016/j.metabol.2011.03.020 CrossRefGoogle Scholar
  13. Goktas S, Yilmaz MI, Caglar K, Sonmez A, Kilic S, Bedir S (2005) Prostate cancer and adiponectin. Urology 65(6):1168–1172. doi:10.1016/j.urology.2004.12.053 PubMedCrossRefGoogle Scholar
  14. Goldstein BJ, Scalia R (2004) Adiponectin: a novel adipokine linking adipocytes and vascular function. J Clin Endocrinol Metab 89(6):2563–2568. doi:10.1210/jc.2004-0518 PubMedCrossRefGoogle Scholar
  15. Gonzalez CR, Caminos JE, Gallego R, Tovar S, Vazquez MJ, Garces MF, Lopez M, Garcia-Caballero T, Tena-Sempere M, Nogueiras R, Dieguez C (2010) Adiponectin receptor 2 is regulated by nutritional status, leptin and pregnancy in a tissue-specific manner. Physiol Behav 99(1):91–99. doi:10.1016/j.physbeh.2009.10.015 PubMedCrossRefGoogle Scholar
  16. Grossmann ME, Nkhata KJ, Mizuno NK, Ray A, Cleary MP (2008) Effects of adiponectin on breast cancer cell growth and signaling. Br J Cancer 98(2):370–379. doi:10.1038/sj.bjc.6604166 PubMedCrossRefGoogle Scholar
  17. Hebbard LW, Garlatti M, Young LJ, Cardiff RD, Oshima RG, Ranscht B (2008) T-cadherin supports angiogenesis and adiponectin association with the vasculature in a mouse mammary tumor model. Cancer Res 68(5):1407–1416. doi:10.1158/0008-5472.CAN-07-2953 PubMedCrossRefGoogle Scholar
  18. Howard JM, Beddy P, Ennis D, Keogan M, Pidgeon GP, Reynolds JV (2010) Associations between leptin and adiponectin receptor upregulation, visceral obesity and tumour stage in oesophageal and junctional adenocarcinoma. Br J Surg 97(7):1020–1027. doi:10.1002/bjs.7072 PubMedCrossRefGoogle Scholar
  19. Ishikawa M, Kitayama J, Yamauchi T, Kadowaki T, Maki T, Miyato H, Yamashita H, Nagawa H (2007) Adiponectin inhibits the growth and peritoneal metastasis of gastric cancer through its specific membrane receptors AdipoR1 and AdipoR2. Cancer Sci 98(7):1120–1127. doi:10.1111/j.1349-7006.2007.00486.x PubMedCrossRefGoogle Scholar
  20. Jeong YJ, Bong JG, Park SH, Choi JH, Oh HK (2011) Expression of leptin, leptin receptor, adiponectin, and adiponectin receptor in ductal carcinoma in situ and invasive breast cancer. J Breast Cancer 14(2):96–103. doi:10.4048/jbc.2011.14.2.96 PubMedCrossRefGoogle Scholar
  21. Kadowaki T, Yamauchi T (2005) Adiponectin and adiponectin receptors. Endocr Rev 26(3):439–451. doi:10.1210/er.2005-0005 PubMedCrossRefGoogle Scholar
  22. Kelesidis I, Kelesidis T, Mantzoros CS (2006) Adiponectin and cancer: a systematic review. Br J Cancer 94(9):1221–1225. doi:10.1038/sj.bjc.6603051 PubMedCrossRefGoogle Scholar
  23. Kim AY, Lee YS, Kim KH, Lee JH, Lee HK, Jang SH, Kim SE, Lee GY, Lee JW, Jung SA, Chung HY, Jeong S, Kim JB (2010) Adiponectin represses colon cancer cell proliferation via AdipoR1- and -R2-mediated AMPK activation. Mol Endocrinol 24(7):1441–1452. doi:10.1210/me.2009-0498 PubMedCrossRefGoogle Scholar
  24. Konturek PC, Burnat G, Rau T, Hahn EG, Konturek S (2008) Effect of adiponectin and ghrelin on apoptosis of Barrett adenocarcinoma cell line. Dig Dis Sci 53(3):597–605. doi:10.1007/s10620-007-9922-1 PubMedCrossRefGoogle Scholar
  25. Korner A, Pazaitou-Panayiotou K, Kelesidis T, Kelesidis I, Williams CJ, Kaprara A, Bullen J, Neuwirth A, Tseleni S, Mitsiades N, Kiess W, Mantzoros CS (2007) Total and high-molecular-weight adiponectin in breast cancer: in vitro and in vivo studies. J Clin Endocrinol Metab 92(3):1041–1048. doi:10.1210/jc.2006-1858 PubMedCrossRefGoogle Scholar
  26. Man K, Ng KT, Xu A, Cheng Q, Lo CM, Xiao JW, Sun BS, Lim ZX, Cheung JS, Wu EX, Sun CK, Poon RT, Fan ST (2010) Suppression of liver tumor growth and metastasis by adiponectin in nude mice through inhibition of tumor angiogenesis and downregulation of Rho kinase/IFN-inducible protein 10/matrix metalloproteinase 9 signaling. Clin Cancer Res Off J Am Assoc Cancer Res 16(3):967–977. doi:10.1158/1078-0432.CCR-09-1487 CrossRefGoogle Scholar
  27. Michalakis K, Williams CJ, Mitsiades N, Blakeman J, Balafouta-Tselenis S, Giannopoulos A, Mantzoros CS (2007) Serum adiponectin concentrations and tissue expression of adiponectin receptors are reduced in patients with prostate cancer: a case control study. Cancer Epidemiol Biomarkers Prev Publ Am Assoc Cancer Res Cosponsored Am Soc Prev Oncol 16(2):308–313. doi:10.1158/1055-9965.EPI-06-0621 CrossRefGoogle Scholar
  28. Mistry T, Digby JE, Chen J, Desai KM, Randeva HS (2006) The regulation of adiponectin receptors in human prostate cancer cell lines. Biochem Biophys Res Commun 348(3):832–838. doi:10.1016/j.bbrc.2006.07.139 PubMedCrossRefGoogle Scholar
  29. Mori M, Sakaguchi H, Akazawa K, Tsuneyoshi M, Sueishi K, Sugimachi K (1995) Correlation between metastatic site, histological type, and serum tumor markers of gastric carcinoma. Hum Pathol 26(5):504–508PubMedCrossRefGoogle Scholar
  30. Nishida M, Funahashi T, Shimomura I (2007) Pathophysiological significance of adiponectin. Med Mol Morphol 40(2):55–67. doi:10.1007/s00795-007-0366-7 PubMedCrossRefGoogle Scholar
  31. Otani K, Kitayama J, Kamei T, Soma D, Miyato H, Yamauchi T, Kadowaki T, Nagawa H (2010) Adiponectin receptors are downregulated in human gastric cancer. J Gastroenterol 45(9):918–927. doi:10.1007/s00535-010-0228-2 PubMedCrossRefGoogle Scholar
  32. Ouchi N, Kobayashi H, Kihara S, Kumada M, Sato K, Inoue T, Funahashi T, Walsh K (2004) Adiponectin stimulates angiogenesis by promoting cross-talk between AMP-activated protein kinase and Akt signaling in endothelial cells. J Biol Chem 279(2):1304–1309. doi:10.1074/jbc.M310389200 PubMedCrossRefGoogle Scholar
  33. Petridou E, Mantzoros C, Dessypris N, Koukoulomatis P, Addy C, Voulgaris Z, Chrousos G, Trichopoulos D (2003) Plasma adiponectin concentrations in relation to endometrial cancer: a case-control study in Greece. J Clin Endocrinol Metab 88(3):993–997PubMedCrossRefGoogle Scholar
  34. Petridou ET, Mitsiades N, Gialamas S, Angelopoulos M, Skalkidou A, Dessypris N, Hsi A, Lazaris N, Polyzos A, Syrigos C, Brennan AM, Tseleni-Balafouta S, Mantzoros CS (2007) Circulating adiponectin levels and expression of adiponectin receptors in relation to lung cancer: two case-control studies. Oncology 73(3–4):261–269. doi:10.1159/000127424 PubMedCrossRefGoogle Scholar
  35. Saxena NK, Fu PP, Nagalingam A, Wang J, Handy J, Cohen C, Tighiouart M, Sharma D, Anania FA (2010) Adiponectin modulates C-jun N-terminal kinase and mammalian target of rapamycin and inhibits hepatocellular carcinoma. Gastroenterology 139 (5):1762–1773, 1773 e1761–1765. doi:10.1053/j.gastro.2010.07.001 Google Scholar
  36. Sugiyama M, Takahashi H, Hosono K, Endo H, Kato S, Yoneda K, Nozaki Y, Fujita K, Yoneda M, Wada K, Nakagama H, Nakajima A (2009) Adiponectin inhibits colorectal cancer cell growth through the AMPK/mTOR pathway. Int J Oncol 34(2):339–344PubMedGoogle Scholar
  37. Tang CH, Lu ME (2009) Adiponectin increases motility of human prostate cancer cells via adipoR, p38, AMPK, and NF-kappaB pathways. Prostate 69(16):1781–1789. doi:10.1002/pros.21029 PubMedCrossRefGoogle Scholar
  38. Tsuchida A, Yamauchi T, Ito Y, Hada Y, Maki T, Takekawa S, Kamon J, Kobayashi M, Suzuki R, Hara K, Kubota N, Terauchi Y, Froguel P, Nakae J, Kasuga M, Accili D, Tobe K, Ueki K, Nagai R, Kadowaki T (2004) Insulin/Foxo1 pathway regulates expression levels of adiponectin receptors and adiponectin sensitivity. J Biol Chem 279(29):30817–30822. doi:10.1074/jbc.M402367200 PubMedCrossRefGoogle Scholar
  39. Tsukada T, Fushida S, Harada S, Terai S, Yagi Y, Kinoshita J, Oyama K, Tajima H, Fujita H, Ninomiya I, Fujimura T, Ohta T (2011) Adiponectin receptor-1 expression is associated with good prognosis in gastric cancer. J Exp Clin Cancer Res CR 30:107. doi:10.1186/1756-9966-30-107 CrossRefGoogle Scholar
  40. Wang Y, Lam JB, Lam KS, Liu J, Lam MC, Hoo RL, Wu D, Cooper GJ, Xu A (2006) Adiponectin modulates the glycogen synthase kinase-3beta/beta-catenin signaling pathway and attenuates mammary tumorigenesis of MDA-MB-231 cells in nude mice. Cancer Res 66(23):11462–11470. doi:10.1158/0008-5472.CAN-06-1969 PubMedCrossRefGoogle Scholar
  41. Wei EK, Giovannucci E, Fuchs CS, Willett WC, Mantzoros CS (2005) Low plasma adiponectin levels and risk of colorectal cancer in men: a prospective study. J Nat Cancer Inst 97(22):1688–1694. doi:10.1093/jnci/dji376 PubMedCrossRefGoogle Scholar
  42. Yamauchi T, Kamon J, Ito Y, Tsuchida A, Yokomizo T, Kita S, Sugiyama T, Miyagishi M, Hara K, Tsunoda M, Murakami K, Ohteki T, Uchida S, Takekawa S, Waki H, Tsuno NH, Shibata Y, Terauchi Y, Froguel P, Tobe K, Koyasu S, Taira K, Kitamura T, Shimizu T, Nagai R, Kadowaki T (2003) Cloning of adiponectin receptors that mediate antidiabetic metabolic effects. Nature 423(6941):762–769. doi:10.1038/nature01705 PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2013

Authors and Affiliations

  • Eun Shin
    • 1
  • Do Joong Park
    • 2
  • Hyung-Ho Kim
    • 2
  • Nam Hee Won
    • 3
  • Gheeyoung Choe
    • 1
  • Hye Seung Lee
    • 1
  1. 1.Department of PathologySeoul National University Bundang HospitalSeongnamSouth Korea
  2. 2.Department of SurgerySeoul National University Bundang HospitalSeongnamSouth Korea
  3. 3.Department of Pathology, College of MedicineKorea UniversitySeongbuk-gu, SeoulSouth Korea

Personalised recommendations